Vor Biopharma Inc. Reports Board and Compensation Changes
Ticker: VOR · Form: 8-K · Filed: Jul 10, 2025 · CIK: 1817229
| Field | Detail |
|---|---|
| Company | Vor Biopharma Inc. (VOR) |
| Form Type | 8-K |
| Filed Date | Jul 10, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, compensation
TL;DR
Vor Bio board shakeup and exec pay changes filed. Details light.
AI Summary
Vor Biopharma Inc. announced on July 9, 2025, a change in its board of directors and executive compensation arrangements. The filing details the departure of a director and the election of a new director, along with updates to compensatory arrangements for certain officers. Specific financial details regarding these changes were not disclosed in this initial filing.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in leadership and compensation can introduce uncertainty, but the filing itself doesn't indicate immediate financial distress or major operational shifts.
Key Players & Entities
- Vor Biopharma Inc. (company) — Registrant
- July 9, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 001-39979 (company_id) — Commission File Number
- 100 Cambridgepark Drive, Suite 101, Cambridge, Massachusetts 02140 (address) — Principal Executive Offices
FAQ
Who departed from Vor Biopharma's board of directors?
The filing indicates the departure of a director, but the specific name is not provided in this section of the 8-K.
Who was elected to Vor Biopharma's board of directors?
The filing states the election of a new director, but the specific name is not disclosed in this section of the 8-K.
What is the date of the earliest event reported in this 8-K filing?
The earliest event reported is dated July 9, 2025.
What are the principal executive offices of Vor Biopharma Inc.?
The principal executive offices are located at 100 Cambridgepark Drive, Suite 101, Cambridge, Massachusetts 02140.
What is the Commission File Number for Vor Biopharma Inc.?
The Commission File Number for Vor Biopharma Inc. is 001-39979.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 10, 2025 regarding Vor Biopharma Inc. (VOR).